世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3873
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・自己細胞療法の市場動向
・企業の競争状況、市場シェア
・自己細胞療法の種類別市場規模と予測2016-2027（骨髄、表皮）
・自己細胞療法の用途別市場規模と予測2016-2027（神経内科、整形外科、がん、創傷治癒、その他）
・自己細胞療法の北米市場規模2016-2027（アメリカ、カナダ）
・自己細胞療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・自己細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・自己細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・自己細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BioTime、Pharmicell、BrainStorm Cell Therapeutics、Opexa Therapeutics、Vericel Corporation、Regeneus）
・結論

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

Market Analysis and Insights: Global Autologous Cell Therapy Market
The global Autologous Cell Therapy market size is projected to reach US$ 16920 million by 2027, from US$ 7231.9 million in 2020, at a CAGR of 12.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autologous Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autologous Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autologous Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autologous Cell Therapy market.

Global Autologous Cell Therapy Scope and Market Size
Autologous Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autologous Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bone Marrow
Epidermis

Segment by Application
Neurology
Orthopedics
Cancer
Wound Healing
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioTime
Pharmicell
BrainStorm Cell Therapeutics
Opexa Therapeutics
Vericel Corporation
Regeneus

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bone Marrow
1.2.3 Epidermis
1.3 Market by Application
1.3.1 Global Autologous Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Neurology
1.3.3 Orthopedics
1.3.4 Cancer
1.3.5 Wound Healing
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autologous Cell Therapy Market Perspective (2016-2027)
2.2 Autologous Cell Therapy Growth Trends by Regions
2.2.1 Autologous Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autologous Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Autologous Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Autologous Cell Therapy Industry Dynamic
2.3.1 Autologous Cell Therapy Market Trends
2.3.2 Autologous Cell Therapy Market Drivers
2.3.3 Autologous Cell Therapy Market Challenges
2.3.4 Autologous Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autologous Cell Therapy Players by Revenue
3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autologous Cell Therapy Revenue
3.4 Global Autologous Cell Therapy Market Concentration Ratio
3.4.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2020
3.5 Autologous Cell Therapy Key Players Head office and Area Served
3.6 Key Players Autologous Cell Therapy Product Solution and Service
3.7 Date of Enter into Autologous Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autologous Cell Therapy Breakdown Data by Type
4.1 Global Autologous Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Autologous Cell Therapy Breakdown Data by Application
5.1 Global Autologous Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autologous Cell Therapy Market Size (2016-2027)
6.2 North America Autologous Cell Therapy Market Size by Type
6.2.1 North America Autologous Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Autologous Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Autologous Cell Therapy Market Size by Type (2016-2027)
6.3 North America Autologous Cell Therapy Market Size by Application
6.3.1 North America Autologous Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Autologous Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Autologous Cell Therapy Market Size by Application (2016-2027)
6.4 North America Autologous Cell Therapy Market Size by Country
6.4.1 North America Autologous Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Autologous Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Autologous Cell Therapy Market Size (2016-2027)
7.2 Europe Autologous Cell Therapy Market Size by Type
7.2.1 Europe Autologous Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Autologous Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Autologous Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Autologous Cell Therapy Market Size by Application
7.3.1 Europe Autologous Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Autologous Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Autologous Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Autologous Cell Therapy Market Size by Country
7.4.1 Europe Autologous Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Autologous Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autologous Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Autologous Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Autologous Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autologous Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autologous Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Autologous Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Autologous Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autologous Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autologous Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Autologous Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Autologous Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autologous Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autologous Cell Therapy Market Size (2016-2027)
9.2 Latin America Autologous Cell Therapy Market Size by Type
9.2.1 Latin America Autologous Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Autologous Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Autologous Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Autologous Cell Therapy Market Size by Application
9.3.1 Latin America Autologous Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Autologous Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Autologous Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Autologous Cell Therapy Market Size by Country
9.4.1 Latin America Autologous Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Autologous Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autologous Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Autologous Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Autologous Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autologous Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autologous Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Autologous Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Autologous Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autologous Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autologous Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Autologous Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Autologous Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autologous Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioTime
11.1.1 BioTime Company Details
11.1.2 BioTime Business Overview
11.1.3 BioTime Autologous Cell Therapy Introduction
11.1.4 BioTime Revenue in Autologous Cell Therapy Business (2016-2021)
11.1.5 BioTime Recent Development
11.2 Pharmicell
11.2.1 Pharmicell Company Details
11.2.2 Pharmicell Business Overview
11.2.3 Pharmicell Autologous Cell Therapy Introduction
11.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2016-2021)
11.2.5 Pharmicell Recent Development
11.3 BrainStorm Cell Therapeutics
11.3.1 BrainStorm Cell Therapeutics Company Details
11.3.2 BrainStorm Cell Therapeutics Business Overview
11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
11.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021)
11.3.5 BrainStorm Cell Therapeutics Recent Development
11.4 Opexa Therapeutics
11.4.1 Opexa Therapeutics Company Details
11.4.2 Opexa Therapeutics Business Overview
11.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
11.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021)
11.4.5 Opexa Therapeutics Recent Development
11.5 Vericel Corporation
11.5.1 Vericel Corporation Company Details
11.5.2 Vericel Corporation Business Overview
11.5.3 Vericel Corporation Autologous Cell Therapy Introduction
11.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2016-2021)
11.5.5 Vericel Corporation Recent Development
11.6 Regeneus
11.6.1 Regeneus Company Details
11.6.2 Regeneus Business Overview
11.6.3 Regeneus Autologous Cell Therapy Introduction
11.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2016-2021)
11.6.5 Regeneus Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bone Marrow
Table 3. Key Players of Epidermis
Table 4. Global Autologous Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Autologous Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autologous Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Autologous Cell Therapy Market Share by Regions (2016-2021)
Table 8. Global Autologous Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Autologous Cell Therapy Market Share by Regions (2022-2027)
Table 10. Autologous Cell Therapy Market Trends
Table 11. Autologous Cell Therapy Market Drivers
Table 12. Autologous Cell Therapy Market Challenges
Table 13. Autologous Cell Therapy Market Restraints
Table 14. Global Autologous Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Autologous Cell Therapy Market Share by Players (2016-2021)
Table 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2020)
Table 17. Ranking of Global Top Autologous Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Autologous Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autologous Cell Therapy Product Solution and Service
Table 21. Date of Enter into Autologous Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Autologous Cell Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Autologous Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Autologous Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Autologous Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Autologous Cell Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Autologous Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Autologous Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autologous Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Autologous Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Autologous Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Autologous Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Autologous Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Autologous Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autologous Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Autologous Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. BioTime Company Details
Table 62. BioTime Business Overview
Table 63. BioTime Autologous Cell Therapy Product
Table 64. BioTime Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million)
Table 65. BioTime Recent Development
Table 66. Pharmicell Company Details
Table 67. Pharmicell Business Overview
Table 68. Pharmicell Autologous Cell Therapy Product
Table 69. Pharmicell Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million)
Table 70. Pharmicell Recent Development
Table 71. BrainStorm Cell Therapeutics Company Details
Table 72. BrainStorm Cell Therapeutics Business Overview
Table 73. BrainStorm Cell Therapeutics Autologous Cell Therapy Product
Table 74. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million)
Table 75. BrainStorm Cell Therapeutics Recent Development
Table 76. Opexa Therapeutics Company Details
Table 77. Opexa Therapeutics Business Overview
Table 78. Opexa Therapeutics Autologous Cell Therapy Product
Table 79. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million)
Table 80. Opexa Therapeutics Recent Development
Table 81. Vericel Corporation Company Details
Table 82. Vericel Corporation Business Overview
Table 83. Vericel Corporation Autologous Cell Therapy Product
Table 84. Vericel Corporation Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million)
Table 85. Vericel Corporation Recent Development
Table 86. Regeneus Company Details
Table 87. Regeneus Business Overview
Table 88. Regeneus Autologous Cell Therapy Product
Table 89. Regeneus Revenue in Autologous Cell Therapy Business (2016-2021) & (US$ Million)
Table 90. Regeneus Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Bone Marrow Features
Figure 3. Epidermis Features
Figure 4. Global Autologous Cell Therapy Market Share by Application: 2020 VS 2027
Figure 5. Neurology Case Studies
Figure 6. Orthopedics Case Studies
Figure 7. Cancer Case Studies
Figure 8. Wound Healing Case Studies
Figure 9. Other Case Studies
Figure 10. Autologous Cell Therapy Report Years Considered
Figure 11. Global Autologous Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Autologous Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Autologous Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Autologous Cell Therapy Market Share by Regions (2022-2027)
Figure 15. Global Autologous Cell Therapy Market Share by Players in 2020
Figure 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2020
Figure 18. Global Autologous Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Autologous Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Autologous Cell Therapy Market Share by Type (2016-2027)
Figure 22. North America Autologous Cell Therapy Market Share by Application (2016-2027)
Figure 23. North America Autologous Cell Therapy Market Share by Country (2016-2027)
Figure 24. United States Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Autologous Cell Therapy Market Share by Type (2016-2027)
Figure 28. Europe Autologous Cell Therapy Market Share by Application (2016-2027)
Figure 29. Europe Autologous Cell Therapy Market Share by Country (2016-2027)
Figure 30. Germany Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Autologous Cell Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Autologous Cell Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Autologous Cell Therapy Market Share by Region (2016-2027)
Figure 40. China Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Autologous Cell Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Autologous Cell Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Autologous Cell Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Autologous Cell Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Autologous Cell Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Autologous Cell Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Autologous Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021)
Figure 60. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021)
Figure 61. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021)
Figure 62. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021)
Figure 63. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021)
Figure 64. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3876 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、自家幹細胞＆非幹細胞系治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞治療、非幹細胞治療）、用途別市場規模（がん、神経変性疾患、循環器疾患、自己免疫疾患、その他）、主要地域別市場規模（...

世界のT細胞療法市場規模・現状・予測（2021年-2027年）

Global T-Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4937 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、T細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCR療法、TIL療法）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要地域別市場規模（北米、アメ...

世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Allogeneic Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3781 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、同種異系幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他）、用途別市場規模（筋骨格系障害、傷＆怪我、心血管疾患、その他）、主要...

世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Tools and Reagents Market Size, Status and Forecast 2021-2027
QFJ1-5121 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、細胞・遺伝子治療用ツール＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学発光免疫測定法（CLIA）、フルオロイムノアッセイ、マルチプレックスアッセイ、迅速診断技術）、用途別市場規模（病院、研...

世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3985 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他）、用途別市場規模（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO...

世界の不死化細胞株市場規模・現状・予測（2021年-2027年）

Global Immortalized Cell Line Market Size, Status and Forecast 2021-2027
QFJ1-4347 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、不死化細胞株の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（幹細胞治療、細胞移植、薬物輸送、その他）、用途別市場規模（製薬＆バイオ医薬品企業、受託研究機関、研究所）、主要地域別市場規模（北米、アメリカ...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界の自家脂肪移植市場規模・現状・予測（2021年-2027年）

Global Autologous Fat Grafting Market Size, Status and Forecast 2021-2027
QFJ1-3875 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、自家脂肪移植の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（統合脂肪移送システム、吸引＆収穫システム、脂肪吸引システム、脂肪処理システム、脱上皮化装置）、用途別市場規模（豊胸手術、豊胸手術、顔面脂肪移...

世界のマントル細胞リンパ腫治療薬市場規模・現状・予測（2021年-2027年）

Global Mantle Cell Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5839 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、マントル細胞リンパ腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の自家幹細胞＆非幹細胞系治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market The global Autologous Stem Cell and Non-Stem Cell Based Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…
世界のT細胞療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global T-Cell Therapy Market The global T-Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell and Gene Therapy Tools and Reagents Market The global Cell and Gene Therapy Tools and Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting …